Christian Schulz

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet · 2019 · 2.2K citations

Medicine, Oncology, Pharmacology +14

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet Oncology · 2020 · 687 citations · Full text

Medicine, Oncology, Pharmacology +14

Evaluating an evidence-based curriculum in undergraduate palliative care education: piloting a phase II exploratory trial for a complex intervention

Christian Schulz, Mischa Möller, Daniel Seidler et al. · BMC Medical Education · 2013 · 241 citations · Full text

Medicine, Curriculum, Medical Education +8

Thrombus NET content is associated with clinical outcome in stroke and myocardial infarction

Julia Novotny, Paul Oberdieck, Anna Titova et al. · Neurology · 2020 · 138 citations · Full text

Life Sciences, Immunology, Pathology +14

Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion

Andreas Schäfer, Christian Schulz, Martin Eigenthaler et al. · Blood · 2003 · 133 citations · Full text

Medicine, Cell Biology, Hematology +16